NCT05209880Completed
Advance Care Planning in the Emergency Department
An Advance Care Planning Intervention in the Emergency Department: a Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 13 Mar 2026
Brief summary (registry, in English)
This is a two-armed, parallel-design, pre-/post-intervention assessment study. The investigators will conduct a randomized controlled trial for ED GOAL on a cohort of 120 older adults with serious illness to collect patient-centered outcomes and determine preliminary efficacy on increasing advance care planning engagement (self-reported and/or in the electronic medical record) one month after leaving the emergency department. The investigators will also conduct qualitative interviews with participants of ED GOAL.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 141 (actual)
- First submitted
- 10 Jan 2022
- Start date
- 1 Mar 2022
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Brigham and Women's Hospital
- Diseases
- Chronic kidney disease, Heart failure, COPD
- NCT number
- NCT05209880
What you commit to
- Study type: Interventional
- Participants enrolled: 141
- From 1 Mar 2022 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Receive both the outpatient care for serious illness and primary care outside of the Mass General Brigham health system
- (\*\*)e.g., MOLST, medical order for life-sustaining treatment, documented serious illness conversations in clinician notes within the last 3 months, etc.
Other
- Acute physical or emotional distress
- Determined by treating or study clinician not to be appropriate
- Clearly documented goals for medical care\*\* (Unless the treating or study clinician recommends that the intervention is clinically indicated)
- Delirium (assessed using 3D-CAM)
- Already enrolled in this study
- Unable/unwilling to schedule the follow-ups on the calendar
Who the study is looking for
- ≥50 years of age AND ≥1 Serious illness\* OR ED clinician would not be surprised if patient died in the next 12 months (a validated prognostic sign)
- English-speaking
- Capacity to consent
- Patient with mild cognitive impairment or mild dementia with capacity to consent (requires a caregiver/study partner to enroll)
- Caregiver of patient with moderate/severe dementia with capacity to consent
- (\*) NYHA Stage III/IV congestive heart failure, chronic obstructive lung disease on home oxygen, chronic kidney disease on dialysis, or metastatic solid tumor cancer. In addition, patients with NYHA Stage I/II congestive heart failure, chronic obstructive lung disease not on home oxygen, chronic kidney disease not on dialysis will be included if recent hospitalization in the last 12 months exists.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Brigham and Women's Hospital Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.